Back
Product details:
CAS
606143-52-6
Purity
95%
Selumetinib is a MEK 1/2 (Dual specificity mitogen-activated protein kinase kinase 1/ 2) inhibitor used in pediatric patients to treat neurofibromatosis type 1 accompanied by symptomatic, inoperable plexiform neurofibromas.
Properties
Name
Selumetinib
Smiles
CN1C=NC=2C(F)=C(NC=3C=CC(Br)=CC3Cl)C(=CC12)C(=O)NOCCO
Targets
Please log in to see this information
Target name
Target pX
Target action
doi
SDS
ARRY-142886 | AZD6244 | refametinib | selumetinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$90
2 mg
$130
5 mg
$240
10 mg
$416
15 mg
$POA
20 mg
$544
25 mg
$672
30 mg
$800
35 mg
$928
40 mg
$1056
45 mg
$1184
50 mg
$1312
75 mg
$2160
100 mg
$POA
Quantity
1
Total amount
$ 240
ARRY-142886 | AZD6244 | refametinib | selumetinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.